Coalition for Epidemic Preparedness Innovations (CEPI). Working to end epidemics & pandemics by developing new vaccines for a safer world. #100DaysMissionhttps://bsky.app/profile/cepi.nethttps://bsky.app/profile/cepi.net/post/3muotq3gzb22qThis week we hosted a landmark pandemic simulation exercise with Indonesia's Ministry of Health to strengthen national and regional readiness against a future ‘Disease X’. Discover more: https://cepi.net/indonesia-steps-southeast-asias-outbreak-preparedness-pandemic-simulation-exercise04 Sep 2026 11:18 +0000at://did:plc:kygof7otstevkulyhp2a3em2/app.bsky.feed.post/3muotq3gzb22qhttps://bsky.app/profile/cepi.net/post/3mumm2y53722kAs global leaders gather for the UN General Assembly High-Level Meeting on Pandemic Prevention, Preparedness and Response, CEPI invites you to join its flagship side event: Building Crisis-Ready Coalitions: From Fragmentation to Readiness. Register now: https://web-eur.cvent.com/event/44c8f5cf-8f8c-4faf-a7de-c130d8b2d323/summary03 Sep 2026 13:55 +0000at://did:plc:kygof7otstevkulyhp2a3em2/app.bsky.feed.post/3mumm2y53722khttps://bsky.app/profile/cepi.net/post/3muhhpqbch22lCEPI's August newsletter is now available ⬇️ This edition spotlights CEPI’s ongoing efforts to close the mpox vaccine access gap, the latest progress in the fight against Bundibugyo ebolavirus—including funding for a fifth vaccine candidate and the initiation of another Phase 1 trial—and lots more. https://www.linkedin.com/pulse/closing-mpox-vaccine-access-gap-mothers-young-children-cepivaccines-zs3we01 Sep 2026 12:54 +0000at://did:plc:kygof7otstevkulyhp2a3em2/app.bsky.feed.post/3muhhpqbch22lhttps://bsky.app/profile/cepi.net/post/3mu2fz5pmj22nWe've announced a new US$16.5 million partnership with African biopharmaceutical company Minapharm Group to develop their Bundibugyo vaccine candidate. The Bundibugyo epidemic in the DRC is the fastest-growing and second-largest Ebola outbreak on record: https://cepi.net/african-bundibugyo-ebolavirus-vaccine-candidate-be-advanced-clinical-trials27 Aug 2026 08:19 +0000at://did:plc:kygof7otstevkulyhp2a3em2/app.bsky.feed.post/3mu2fz5pmj22nhttps://bsky.app/profile/cepi.net/post/3mtvpmvuk4k2x100 days into the Bundibugyo emergency, the global health response has moved at a pace unimaginable a decade ago. Yet the outbreak is far from contained. It's painful proof that in a deadly epidemic, even faster than ever is often not fast enough. ➡️ Read more on our website: https://cepi.net/100-days-bundibugyo-emergency-unprecedented-speed-still-not-enough25 Aug 2026 11:28 +0000at://did:plc:kygof7otstevkulyhp2a3em2/app.bsky.feed.post/3mtvpmvuk4k2xhttps://bsky.app/profile/cepi.net/post/3mtitbsblnc2bDo existing vaccines against Zaire ebolavirus generate immune responses to Bundibugyo ebolavirus? https://www.cepi.net/new-studies-test-whether-existing-ebola-vaccines-can-generate-immune-responses-bundibugyo20 Aug 2026 08:28 +0000at://did:plc:kygof7otstevkulyhp2a3em2/app.bsky.feed.post/3mtitbsblnc2bhttps://bsky.app/profile/cepi.net/post/3mt266mjrks2zWe’re delighted to announce that the CEPI Board has appointed Professor Ibrahim Abubakar as CEPI’s next Chief Executive Officer. https://cepi.net/cepi-board-appoints-ibrahim-abubakar-new-chief-executive-officer14 Aug 2026 12:34 +0000at://did:plc:kygof7otstevkulyhp2a3em2/app.bsky.feed.post/3mt266mjrks2zhttps://bsky.app/profile/cepi.net/post/3msbduili522uThe first participant has been dosed in a CEPI-backed Phase 1 trial of Moderna's investigational vaccine against Bundibugyo virus, marking rapid progress in the global effort to combat the deadly Ebola outbreak in DRC. Read more: https://cepi.net/modernas-bundibugyo-ebolavirus-vaccine-candidate-enters-first-human-trial-backed-cepi04 Aug 2026 15:39 +0000at://did:plc:kygof7otstevkulyhp2a3em2/app.bsky.feed.post/3msbduili522uhttps://bsky.app/profile/cepi.net/post/3msbduili522uThe first participant has been dosed in a CEPI-backed Phase 1 trial of Moderna's investigational vaccine against Bundibugyo virus, marking rapid progress in the global effort to combat the deadly Ebola outbreak in DRC. Read more: https://cepi.net/modernas-bundibugyo-ebolavirus-vaccine-candidate-enters-first-human-trial-backed-cepi04 Aug 2026 15:39 +0000at://did:plc:kygof7otstevkulyhp2a3em2/app.bsky.feed.post/3msbduili522uhttps://bsky.app/profile/cepi.net/post/3ms6efs3am22lThe Bundibugyo Ebola epidemic in the Democratic Republic of the Congo has passed a tragic milestone. Just 11 weeks after it was declared, the outbreak has reached 3,748 confirmed cases, making it the second-largest Ebola outbreak in history and the fastest-growing ever recorded.03 Aug 2026 11:10 +0000at://did:plc:kygof7otstevkulyhp2a3em2/app.bsky.feed.post/3ms6efs3am22lhttps://bsky.app/profile/cepi.net/post/3mruqldwbok2jCEPI's July newsletter is now available 🗞️ Explore the latest progress in the fight against the fastest-growing Ebola outbreak on record, along with new CEPI 3.0 campaign resources, open Calls for Proposals and lots more ⬇️ https://www.linkedin.com/pulse/bundibugyo-virus-death-toll-mounts-hope-horizon-cepivaccines-rokze30 Jul 2026 15:22 +0000at://did:plc:kygof7otstevkulyhp2a3em2/app.bsky.feed.post/3mruqldwbok2jhttps://bsky.app/profile/cepi.net/post/3mruclls5rk2cWith the Bundibugyo outbreak the fastest-growing Ebola epidemic on record, CEPI is providing up to $8.5m to Hilleman Laboratories, a joint MSD-Wellcome Trust venture, to accelerate development and manufacture of an rVSV vaccine candidate for clinical trials. https://cepi.net/hilleman-laboratories-develop-and-produce-cepi-backed-bundibugyo-ebolavirus-vaccine-doses-clinical30 Jul 2026 11:11 +0000at://did:plc:kygof7otstevkulyhp2a3em2/app.bsky.feed.post/3mruclls5rk2chttps://bsky.app/profile/cepi.net/post/3mrn2avhtu22qA powerful affirmation from Institut Pasteur de Dakar CEO Dr. Ibrahima Socé Fall, one of CEPI's key manufacturing partners, on the need for an organisation like CEPI and why continued investment in CEPI 3.0 is critical for our collective global health security ⬇️27 Jul 2026 13:53 +0000at://did:plc:kygof7otstevkulyhp2a3em2/app.bsky.feed.post/3mrn2avhtu22qhttps://bsky.app/profile/cepi.net/post/3mrfmowjkzc2bThe first volunteer has been vaccinated with the @ox.ac.uk's Bundibugyo ebolavirus vaccine candidate in a CEPI-backed clinical trial as efforts ramp up to contain a fast-spreading and deadly outbreak affecting the Democratic Republic of the Congo. Read more: https://www.ox.ac.uk/news/2026-07-24-first-volunteer-vaccinated-in-the-worlds-first-bundibugyo-ebolavirus-vaccine-trial24 Jul 2026 15:02 +0000at://did:plc:kygof7otstevkulyhp2a3em2/app.bsky.feed.post/3mrfmowjkzc2bhttps://bsky.app/profile/cepi.net/post/3mqrixf5smc2fICYMI: a CEPI-backed vaccine candidate developed by the University of Oxford became the first vaccine targeting Bundibugyo virus to enter Phase I trials, just 57 days after the WHO declared the outbreak a public health emergency. The Independent reports ⬇️ https://www.independent.co.uk/news/health/ebola-vaccine-oxford-university-bundibugyo-b3013787.html16 Jul 2026 15:02 +0000at://did:plc:kygof7otstevkulyhp2a3em2/app.bsky.feed.post/3mqrixf5smc2fhttps://bsky.app/profile/cepi.net/post/3mq7ihbsaqs2qIn our new blog, CEPI's Chief Scientific Writer Kate Kelland asked Aurélia Nguyen, CEPI’s Deputy CEO, to explain how CEPI is supporting the global response to the Bundibugyo outbreak and how that work aligns with the 100 Days Mission. Read the new Q&A to learn more: https://cepi.net/bundibugyo-and-100-days-mission-preparedness-readiness-and-response09 Jul 2026 11:05 +0000at://did:plc:kygof7otstevkulyhp2a3em2/app.bsky.feed.post/3mq7ihbsaqs2qhttps://bsky.app/profile/cepi.net/post/3mq57wdtywc2qCEPI has recently published its 2025 Annual Progress Report – a timely reflection of a year that reinforced why epidemic and pandemic preparedness is more important than ever. Read it here: https://static.cepi.net/downloads/2026-07/CEPI%202025%20Annual%20Progress%20Report_FINAL.pdf08 Jul 2026 13:27 +0000at://did:plc:kygof7otstevkulyhp2a3em2/app.bsky.feed.post/3mq57wdtywc2qhttps://bsky.app/profile/cepi.net/post/3mq2dpcqrsk2qOur recent Innovations for Impact story takes a closer look at this clinical trial site in Bauchi, Nigeria, and the impact it is already helping to deliver in the region. Read it here ➡️ https://cepi.net/innovations-for-impact/outbreak-ready-research-ready-strengthening-west-africas-research-ecosystem [contains quote post or other embedded content]07 Jul 2026 09:57 +0000at://did:plc:kygof7otstevkulyhp2a3em2/app.bsky.feed.post/3mq2dpcqrsk2qhttps://bsky.app/profile/cepi.net/post/3mpntwtz37s27CEPI has announced updates to its Scientific Advisory Committee, an external expert group providing independent scientific guidance across R&D programmes and outbreak preparedness activities. More: https://cepi.net/new-experts-appointed-cepis-scientific-advisory-committee02 Jul 2026 10:43 +0000at://did:plc:kygof7otstevkulyhp2a3em2/app.bsky.feed.post/3mpntwtz37s27https://bsky.app/profile/cepi.net/post/3mplmhcoea22rCEPI's latest newsletter is now available 🗞️ Dive in to explore the latest in epidemic and pandemic preparedness, including CEPI's Global Vaccine Manufacturing Summit, new investments to combat the Bundibugyo ebolavirus outbreak, CEPI 3.0 campaign updates and more. https://www.linkedin.com/pulse/vaccine-manufacturing-bridge-between-science-impact-cepivaccines-2jjge01 Jul 2026 13:23 +0000at://did:plc:kygof7otstevkulyhp2a3em2/app.bsky.feed.post/3mplmhcoea22rhttps://bsky.app/profile/cepi.net/post/3mpitvtm7es2fEarlier this month, researchers in our Preclinical Model and Centralised Laboratory Networks met up in Cape Town, South Africa, to discuss how they can strengthen collaboration and make the goal of developing a vaccine in 100 days a reality. Discover more in this Q+A: https://cepi.net/lab-scientists-banding-together-test-new-outbreak-busting-vaccines-030 Jun 2026 10:59 +0000at://did:plc:kygof7otstevkulyhp2a3em2/app.bsky.feed.post/3mpitvtm7es2fhttps://bsky.app/profile/cepi.net/post/3mnf7i2hdbk2iNew funding from CEPI will help take a promising nanoparticle vaccine platform into early clinical development, with the aim of speeding up how we respond to future outbreaks. More ⬇️ https://cepi.net/cepi-funds-next-phase-nanoparticle-vaccine-platform-support-rapid-outbreak-response03 Jun 2026 13:25 +0000at://did:plc:kygof7otstevkulyhp2a3em2/app.bsky.feed.post/3mnf7i2hdbk2ihttps://bsky.app/profile/cepi.net/post/3mn7ubiyjwc26🔉 CEPI is urgently accelerating the development of three investigational vaccine candidates towards clinical trials in response to the deeply concerning Bundibugyo ebolavirus epidemic. More in the press release ⬇️ https://cepi.net/cepi-fast-tracks-three-bundibugyo-ebolavirus-vaccine-candidates01 Jun 2026 10:21 +0000at://did:plc:kygof7otstevkulyhp2a3em2/app.bsky.feed.post/3mn7ubiyjwc26https://bsky.app/profile/cepi.net/post/3mnadap2ynk2jCEPI's latest newsletter is now available! From funding to accelerate clinical develop of three #Bundibugyo virus vaccine candidates to renewed commitments to support CEPI 3.0, a lot has happened over the last month. Catch up: https://www.linkedin.com/pulse/bundibugyo-spreads-cepi-accelerates-new-vaccine-candidates-avyfe01 Jun 2026 14:49 +0000at://did:plc:kygof7otstevkulyhp2a3em2/app.bsky.feed.post/3mnadap2ynk2jhttps://bsky.app/profile/cepi.net/post/3mnadcvjysk2jCEPI has launched an urgent Call for Proposals seeking to accelerate early‑stage vaccine candidates against Bundibugyo virus (BDBV). Eligibility and how to apply: https://cepi.my.site.com/call-for-proposal?id=a1zP3000008XbgvIAC01 Jun 2026 14:50 +0000at://did:plc:kygof7otstevkulyhp2a3em2/app.bsky.feed.post/3mnadcvjysk2jhttps://bsky.app/profile/cepi.net/post/3mnadcvjysk2jCEPI has launched an urgent Call for Proposals seeking to accelerate early‑stage vaccine candidates against Bundibugyo virus (BDBV). Eligibility and how to apply: https://cepi.my.site.com/call-for-proposal?id=a1zP3000008XbgvIAC01 Jun 2026 14:50 +0000at://did:plc:kygof7otstevkulyhp2a3em2/app.bsky.feed.post/3mnadcvjysk2jhttps://bsky.app/profile/cepi.net/post/3mnadap2ynk2jCEPI's latest newsletter is now available! From funding to accelerate clinical develop of three #Bundibugyo virus vaccine candidates to renewed commitments to support CEPI 3.0, a lot has happened over the last month. Catch up: https://www.linkedin.com/pulse/bundibugyo-spreads-cepi-accelerates-new-vaccine-candidates-avyfe01 Jun 2026 14:49 +0000at://did:plc:kygof7otstevkulyhp2a3em2/app.bsky.feed.post/3mnadap2ynk2j